Oric Pharmaceuticals, Inc. (ORIC)
13.42
+1.71
(+14.60%)
USD |
NASDAQ |
Feb 24, 16:00
13.75
+0.33
(+2.46%)
After-Hours: 17:26
Oric Pharmaceuticals Research and Development Expense (Quarterly) : 28.77M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 4.268B |
| Pfizer Inc. | 3.206B |
| Krystal Biotech, Inc. | 13.23M |
| Olema Pharmaceuticals, Inc. | 39.95M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |